Try the modernized beta website. Learn more about the modernization effort.

Key Record Dates Identifier: NCT04700072
Brief Title: Substudy 02D: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Melanoma Brain Metastasis (MK-3475-02D/KEYMAKER-U02)

First Submitted : January 5, 2021
First Submitted that Met QC Criteria : January 5, 2021
First Posted : January 7, 2021

Last Update Submitted that Met QC Criteria : November 25, 2021
Last Update Posted : November 29, 2021